STRATA Skin Sciences Future Growth
Future criteria checks 1/6
STRATA Skin Sciences is forecast to grow earnings and revenue by 39.7% and 7.3% per annum respectively while EPS is expected to grow by 47.8% per annum.
Key information
39.7%
Earnings growth rate
47.8%
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | 7.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Aug 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 40 | -2 | N/A | 7 | 1 |
| 12/31/2025 | 34 | -6 | N/A | 3 | 2 |
| 12/31/2024 | 33 | -7 | N/A | 0 | 1 |
| 6/30/2024 | 33 | -8 | -3 | -1 | N/A |
| 3/31/2024 | 33 | -11 | -4 | -1 | N/A |
| 12/31/2023 | 33 | -11 | -6 | -1 | N/A |
| 9/30/2023 | 35 | -7 | -6 | -1 | N/A |
| 6/30/2023 | 36 | -7 | -6 | 0 | N/A |
| 3/31/2023 | 37 | -6 | -6 | -1 | N/A |
| 12/31/2022 | 36 | -6 | -5 | -1 | N/A |
| 9/30/2022 | 35 | -6 | -4 | 0 | N/A |
| 6/30/2022 | 33 | -6 | -3 | 1 | N/A |
| 3/31/2022 | 31 | -3 | -3 | 1 | N/A |
| 12/31/2021 | 30 | -3 | -2 | 2 | N/A |
| 9/30/2021 | 28 | -2 | -2 | 1 | N/A |
| 6/30/2021 | 26 | -3 | -2 | 1 | N/A |
| 3/31/2021 | 22 | -6 | -1 | 2 | N/A |
| 12/31/2020 | 23 | -4 | 0 | 2 | N/A |
| 9/30/2020 | 25 | -4 | N/A | 3 | N/A |
| 6/30/2020 | 27 | -4 | 0 | 3 | N/A |
| 3/31/2020 | 31 | -3 | 0 | 2 | N/A |
| 12/31/2019 | 32 | -4 | -1 | 2 | N/A |
| 9/30/2019 | 31 | -3 | 0 | 2 | N/A |
| 6/30/2019 | 31 | -3 | 2 | 3 | N/A |
| 3/31/2019 | 31 | -3 | 1 | 3 | N/A |
| 12/31/2018 | 30 | -4 | 1 | 3 | N/A |
| 9/30/2018 | 31 | -9 | 2 | 4 | N/A |
| 6/30/2018 | 30 | -22 | 1 | 2 | N/A |
| 3/31/2018 | 31 | -21 | N/A | 3 | N/A |
| 12/31/2017 | 32 | -22 | N/A | 4 | N/A |
| 9/30/2017 | 30 | -18 | N/A | 4 | N/A |
| 6/30/2017 | 31 | -6 | N/A | 4 | N/A |
| 3/31/2017 | 30 | -4 | N/A | 3 | N/A |
| 12/31/2016 | 31 | -3 | N/A | 0 | N/A |
| 9/30/2016 | 33 | -3 | N/A | -1 | N/A |
| 6/30/2016 | 33 | -14 | N/A | -3 | N/A |
| 3/31/2016 | 26 | -22 | N/A | -5 | N/A |
| 12/31/2015 | 18 | -28 | N/A | -7 | N/A |
| 9/30/2015 | 9 | -34 | N/A | -10 | N/A |
| 6/30/2015 | 1 | -24 | N/A | -12 | N/A |
| 3/31/2015 | 1 | -15 | N/A | -14 | N/A |
| 12/31/2014 | 1 | -16 | N/A | -18 | N/A |
| 9/30/2014 | 1 | -14 | N/A | -19 | N/A |
| 6/30/2014 | 1 | -19 | N/A | -20 | N/A |
| 3/31/2014 | 0 | -27 | N/A | -20 | N/A |
| 12/31/2013 | 1 | -26 | N/A | -19 | N/A |
| 9/30/2013 | 1 | -27 | N/A | -21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: E2O is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: E2O is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: E2O is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: E2O's revenue (7.3% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: E2O's revenue (7.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if E2O's Return on Equity is forecast to be high in 3 years time